Hereditary cancer predisposition syndromes.

By J. Garber, K. Offit. Journal of Clinical Oncology, 2005

651 citations recorded by the source corpus.

Subfields: Genetics, Pathology and Forensic Medicine

View Paper: https://www.semanticscholar.org/paper/62fe0b2dbcc2a11d68662a9f32bdcdb72580e1e2

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

1. A. Goldhirsch
2. A. Coates
3. R. Gelber
4. B. Thürlimann
5. H. Senn
6. Panel Members
7. J. Glick
8. E. Sickles

Citations in the corpus

• Meeting highlights: international expert consensus on the primary therapy of early breast cancer 2005. (2005, background): “BRCA1 and BRCA2 mutation carriers benefit from prophylactic strategies including bilateral oophorectomy [10, 11], bilateral mastectomy with reconstruction [12] and chemoprevention, while the role of intensified surveillance is controversial [13].”
• Breast cancer screening with imaging: recommendations from the Society of Breast Imaging and the ACR on the use of mammography, breast MRI, breast ultrasound, and other technologies for the detection of clinically occult breast cancer. (2010, background): “The PTEN gene, associated with Cowden’s syndrome, the p53 gene of Li-Fraumeni syndrome, and Muir-Torres syndrome (the MSH2 and MLH1 genes) are rare and seem to convey increased breast cancer risk [48].”